{"id":"https://openalex.org/W2161908800","doi":"https://doi.org/10.1016/s0026-895x(24)12195-5","title":"The Cyclopentenone Prostaglandin 15-Deoxy-\u039412,14-Prostaglandin J2Attenuates the Development of Acute and Chronic Inflammation","display_name":"The Cyclopentenone Prostaglandin 15-Deoxy-\u039412,14-Prostaglandin J2Attenuates the Development of Acute and Chronic Inflammation","alternate_titles":[],"publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2161908800","doi":"https://doi.org/10.1016/s0026-895x(24)12195-5","mag":"2161908800","pmid":"https://pubmed.ncbi.nlm.nih.gov/11961117"},"language":"en","primary_location":{"id":"doi:10.1016/s0026-895x(24)12195-5","doi":"https://doi.org/10.1016/s0026-895x(24)12195-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0026-895x(24)12195-5","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2161908800"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074289588","display_name":"Salvatore Cuzzocrea","orcid":"https://orcid.org/0000-0001-6131-3690","observed_orcids":["https://orcid.org/0000-0001-6131-3690"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Salvatore Cuzzocrea","raw_affiliation_strings":["Institute of Pharmacology, School of Medicine, University of Messina, Messina, Italy. salvator@unime.it","1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, School of Medicine, University of Messina, Messina, Italy. salvator@unime.it","institution_ids":["https://openalex.org/I112862951"]},{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049352252","display_name":"Nicole S. Wayman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicole S. Wayman","raw_affiliation_strings":["3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom","institution_ids":["https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040381615","display_name":"Emanuela Mazzon","orcid":"https://orcid.org/0000-0002-5073-717X","observed_orcids":["https://orcid.org/0000-0002-5073-717X"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuela Mazzon","raw_affiliation_strings":["1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010579197","display_name":"Laura Dugo","orcid":"https://orcid.org/0000-0001-5527-0364","observed_orcids":["https://orcid.org/0000-0001-5527-0364"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Dugo","raw_affiliation_strings":["1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053839749","display_name":"Rosanna Di Paola","orcid":"https://orcid.org/0000-0001-6725-8581","observed_orcids":["https://orcid.org/0000-0001-6725-8581"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosanna Di Paola","raw_affiliation_strings":["1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065984581","display_name":"Ivana Serraino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ivana Serraino","raw_affiliation_strings":["1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088201710","display_name":"Domenico Britti","orcid":"https://orcid.org/0000-0001-7355-8791","observed_orcids":["https://orcid.org/0000-0001-7355-8791"]},"institutions":[{"id":"https://openalex.org/I124326101","display_name":"University of Teramo","ror":"https://ror.org/01yetye73","country_code":"IT","type":"education","lineage":["https://openalex.org/I124326101"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenico Britti","raw_affiliation_strings":["4Department of Veterinary and Agricultural Science, University of Teramo, Teramo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Veterinary and Agricultural Science, University of Teramo, Teramo, Italy","institution_ids":["https://openalex.org/I124326101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113512390","display_name":"Prabal Kumar Chatterjee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Prabal K. Chatterjee","raw_affiliation_strings":["3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom","institution_ids":["https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111749872","display_name":"Achille Patrizio Caputi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Achille P. Caputi","raw_affiliation_strings":["1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Pharmacology,\n2Department of Biomorphology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005920096","display_name":"Christoph Thiemermann","orcid":"https://orcid.org/0000-0003-4228-9722","observed_orcids":["https://orcid.org/0000-0003-4228-9722"]},"institutions":[{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christoph Thiemermann","raw_affiliation_strings":["3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Experimental Medicine and Nephrology, the William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, United Kingdom","institution_ids":["https://openalex.org/I4210149920"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":6.8412,"has_fulltext":false,"cited_by_count":129,"citation_normalized_percentile":{"value":0.97234125,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"61","issue":"5","first_page":"997","last_page":"1007"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.33250001072883606,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/15-deoxy-delta12-14-prostaglandin-j2","display_name":"15-deoxy-\u039412,14-prostaglandin J2","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cyclopentenone-prostaglandins","display_name":"cyclopentenone prostaglandins","score":0.9779999852180481},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.8349999785423279},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/acute-inflammation","display_name":"acute inflammation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/chronic-inflammation","display_name":"chronic inflammation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/carrageenan-induced-pleurisy","display_name":"carrageenan-induced pleurisy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/collagen-induced-arthritis","display_name":"collagen-induced arthritis","score":1.0},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.5879999995231628},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9909999966621399},{"id":"https://openalex.org/keywords/3-nitrotyrosine","display_name":"nitrotyrosine","score":0.953000009059906},{"id":"https://openalex.org/keywords/poly-adp-ribose-polymerase","display_name":"poly(ADP-ribose) polymerase","score":0.9390000104904175},{"id":"https://openalex.org/keywords/pleural-exudate","display_name":"pleural exudate","score":0.7839999794960022},{"id":"https://openalex.org/keywords/mononuclear-cell-infiltration","display_name":"mononuclear cell infiltration","score":0.9660000205039978}],"concepts":[{"id":"https://openalex.org/C2777903533","wikidata":"https://www.wikidata.org/wiki/Q2292678","display_name":"Cyclopentenone","level":2,"score":0.925110399723053},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.7050473690032959},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.7000207901000977},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5479465126991272},{"id":"https://openalex.org/C2777198256","wikidata":"https://www.wikidata.org/wiki/Q4860325","display_name":"Prostaglandin E","level":2,"score":0.44333210587501526},{"id":"https://openalex.org/C3019158842","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin f","level":3,"score":0.44313159584999084},{"id":"https://openalex.org/C2777361909","wikidata":"https://www.wikidata.org/wiki/Q419750","display_name":"Prostaglandin D2","level":3,"score":0.43819957971572876},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3447467088699341},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3118157982826233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2777591049671173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2676815986633301}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002351","descriptor_name":"Carrageenan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010998","descriptor_name":"Pleurisy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010998","descriptor_name":"Pleurisy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010998","descriptor_name":"Pleurisy","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0026-895x(24)12195-5","doi":"https://doi.org/10.1016/s0026-895x(24)12195-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0026-895x(24)12195-5","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"doi:10.1124/mol.61.5.997","doi":"https://doi.org/10.1124/mol.61.5.997","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.61.5.997","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:11961117","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11961117","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/77164f7e-dac1-4039-87fb-1b9e1e7f0258","doi":null,"is_oa":false,"landing_page_url":"http://molpharm.aspetjournals.org/cgi/content/abstract/61/5/997","pdf_url":null,"source":{"id":"https://openalex.org/S4306401758","display_name":"University of Brighton Repository (University of Brighton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71637028","host_organization_name":"University of Brighton","host_organization_lineage":["https://openalex.org/I71637028"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cuzzocrea, S, Wayman, N S, Mazzon, E, Dugo, L, Di Paola, R, Serraino, I, Britti, D, Chatterjee, P K, Caputi, A P & Thiemermann, C 2002, 'The Cyclopentenone Prostaglandin 15-Deoxy-Delta 12,14-Prostaglandin J2 attenuates the development of acute and chronic inflammation', Molecular Pharmacology, vol. 61, no. 5, pp. 997-1007. https://doi.org/10.1124/mol.61.5.997","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1583731895","https://openalex.org/W1584270516","https://openalex.org/W1633340712","https://openalex.org/W1639924204","https://openalex.org/W1725300350","https://openalex.org/W1919498211","https://openalex.org/W1964531991","https://openalex.org/W1971175717","https://openalex.org/W1976468624","https://openalex.org/W1983310681","https://openalex.org/W1987414503","https://openalex.org/W1989619519","https://openalex.org/W1991484350","https://openalex.org/W1993535520","https://openalex.org/W1997051387","https://openalex.org/W1997545468","https://openalex.org/W2007354513","https://openalex.org/W2012810767","https://openalex.org/W2027193949","https://openalex.org/W2038371393","https://openalex.org/W2047010027","https://openalex.org/W2050576725","https://openalex.org/W2055703298","https://openalex.org/W2058218787","https://openalex.org/W2059829735","https://openalex.org/W2063873306","https://openalex.org/W2074880086","https://openalex.org/W2076353960","https://openalex.org/W2078259729","https://openalex.org/W2093585097","https://openalex.org/W2124371647","https://openalex.org/W2128635872","https://openalex.org/W2146498309","https://openalex.org/W4240789623"],"related_works":["https://openalex.org/W4404595762","https://openalex.org/W4290374908","https://openalex.org/W1994659489","https://openalex.org/W2120851100","https://openalex.org/W2052990800","https://openalex.org/W2089731541","https://openalex.org/W2076480589","https://openalex.org/W1812573520","https://openalex.org/W2091704534"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2161908800","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
